Your browser doesn't support javascript.
loading
A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.
Haran, Michal; Mirkin, Vita; Braester, Andrei; Harpaz, Nurith; Shevetz, Olga; Shtreiter, Marina; Greenberg, Shulamit; Mordich, Orly; Amram, Orna; Binsky-Ehrenreich, Inbal; Marom, Ayelet; Shachar, Idit; Herishanu, Yair; Ruchlemer, Rosa; Berrebi, Alain; Valinsky, Liora; Shtalrid, Mordechai; Shvidel, Lev.
Afiliação
  • Haran M; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Mirkin V; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Braester A; Haematology Institute, Galilee Medical Centre, Nahariya, Israel.
  • Harpaz N; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Shevetz O; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Shtreiter M; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Greenberg S; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Mordich O; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Amram O; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Binsky-Ehrenreich I; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Marom A; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Shachar I; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Herishanu Y; Department of Haematology, Sourasky Medical Centre and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Ruchlemer R; Department of Haematology, Shaare Zedek, Jerusalem, Israel.
  • Berrebi A; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Valinsky L; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Shtalrid M; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
  • Shvidel L; Haematology Institute, Kaplan Medical Centre, affiliated with the Hebrew University, Rehovot, Israel.
Br J Haematol ; 182(1): 125-128, 2018 07.
Article em En | MEDLINE | ID: mdl-28466956
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Israel